Pharmaceuticals

Global Sartans Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Sartans Industry In 2025?

The sartans market size has seen steady expansion in recent years. It is projected to increase from $21.36 billion in 2024 to $22.18 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.8%. This historical growth can be attributed to factors such as the growing adoption of sedentary lifestyles, an increasing incidence of obesity, rising awareness about cardiovascular diseases, increasing healthcare expenditure, and a rising demand for generic antihypertensive drugs.

The sartans market size is expected to show consistent expansion in the coming years, reaching $26.07 billion by 2029, with a compound annual growth rate (CAGR) of 4.1%. This increase over the forecast period is primarily driven by an increased emphasis on combination therapies, growing investments in pharmaceutical research and development, rising demand from emerging markets, the expansion of healthcare infrastructure, and the increasing prevalence of lifestyle-related disorders. Significant trends anticipated during this period involve advancements in drug delivery technologies, sophisticated manufacturing processes for active pharmaceutical ingredients (APIs), the development of fixed-dose combination drugs, innovations in personalized hypertension treatment, and the creation of novel sartan derivatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Which Industry Drivers Are Expected To Accelerate The Sartans Market From 2025 To 2029?

The increasing occurrence of hypertension is anticipated to fuel the expansion of the sartans market in the future. This condition, known as hypertension, is characterized by chronically elevated blood pressure, potentially increasing the risk of heart disease, stroke, and other serious medical issues. An escalating rate of hypertension is associated with diets high in salt and processed items, contributing to fluid retention and a greater strain on the heart. Sartans address hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and broadening the vessels, thereby reducing blood pressure and alleviating the heart’s effort. For example, in January 2024, as reported by the American Heart Association, a US-based nonprofit organization, high blood pressure was a primary contributing factor in 131,454 deaths in 2022, marking an increase from 124,508 deaths recorded in 2021. Consequently, the expanding prevalence of hypertension is a key factor propelling the growth of the sartans market.

What Are The Different Segment Classifications Within The Sartans Market?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

How Are Emerging Market Trends Shaping The Sartans Industry Landscape?

Leading companies within the sartans market are concentrating on developing innovative products, such as sartans in tablet form, with the aim of boosting treatment effectiveness and patient compliance. Tablet-form sartans are oral medications that incorporate sartan drugs, which work by blocking the effects of angiotensin II, thereby promoting the relaxation of blood vessels and reducing blood pressure. For example, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, obtained US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are sold commercially under the brand name Diovan. The tablets are prescribed for the treatment of hypertension and heart failure, and to enhance survival following a heart attack in adults; they are also appropriate for pediatric patients aged one year and older.

Which Major Firms Are Strengthening Their Position In The Sartans Industry?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

Which Regional Markets Are Contributing Most To The Sartans Industry Expansion?

North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sartans Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp

Browse Through More Reports Similar to the Global Sartans Market 2025, By The Business Research Company

Central Nervous System Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795